世界の皮下免疫グロブリン市場予測 2020年-2025年

【英語タイトル】Global Subcutaneous Immunoglobulins Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP4677)・商品コード:LPI20AP4677
・発行会社(調査会社):LP Information
・発行日:2020年3月27日(※2024年版があります。お問い合わせください)
・ページ数:132
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「皮下免疫グロブリンの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、純度10%、純度20%など、用途別には、一次免疫不全、二次免疫不全、その他などに区分してまとめた調査レポートです。皮下免疫グロブリンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・皮下免疫グロブリンの世界市場概要(サマリー)
・皮下免疫グロブリンの企業別販売量・売上
・皮下免疫グロブリンの企業別市場シェア
・皮下免疫グロブリンの世界市場規模 2015年-2020年:種類別(純度10%、純度20%)
・皮下免疫グロブリンの世界市場規模 2015年-2020年:用途別(一次免疫不全、二次免疫不全、その他)
・皮下免疫グロブリンの米州市場規模(アメリカ、カナダ、メキシコなど)
・皮下免疫グロブリンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・皮下免疫グロブリンの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・皮下免疫グロブリンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・皮下免疫グロブリン市場の成長要因・課題・動向
・皮下免疫グロブリンの世界市場予測 2021年-2025年
・皮下免疫グロブリンの米州市場予測(アメリカ、カナダ、メキシコなど)
・皮下免疫グロブリンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・皮下免疫グロブリンの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・皮下免疫グロブリンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・皮下免疫グロブリンの世界市場予測:種類別(純度10%、純度20%)
・皮下免疫グロブリンの世界市場予測:用途別(一次免疫不全、二次免疫不全、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Subcutaneous Immunoglobulins market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Subcutaneous Immunoglobulins business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Immunoglobulins market by type, application, key manufacturers and key regions and countries.

This study considers the Subcutaneous Immunoglobulins value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
10% Purity
20% Purity

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Primary Immunodeficiency
Secondary Immunodeficiency
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Shire (Baxalta)
Grifols
CSL

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Subcutaneous Immunoglobulins consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Subcutaneous Immunoglobulins market by identifying its various subsegments.
Focuses on the key global Subcutaneous Immunoglobulins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Subcutaneous Immunoglobulins with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Subcutaneous Immunoglobulins submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Subcutaneous Immunoglobulins Consumption 2015-2025
2.1.2 Subcutaneous Immunoglobulins Consumption CAGR by Region
2.2 Subcutaneous Immunoglobulins Segment by Type
2.2.1 10% Purity
2.2.2 20% Purity
2.3 Subcutaneous Immunoglobulins Consumption by Type
2.3.1 Global Subcutaneous Immunoglobulins Consumption Market Share by Type (2015-2020)
2.3.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Type (2015-2020)
2.3.3 Global Subcutaneous Immunoglobulins Sale Price by Type (2015-2020)
2.4 Subcutaneous Immunoglobulins Segment by Application
2.4.1 Primary Immunodeficiency
2.4.2 Secondary Immunodeficiency
2.4.3 Others
2.5 Subcutaneous Immunoglobulins Consumption by Application
2.5.1 Global Subcutaneous Immunoglobulins Consumption Market Share by Type (2015-2020)
2.5.2 Global Subcutaneous Immunoglobulins Value and Market Share by Type (2015-2020)
2.5.3 Global Subcutaneous Immunoglobulins Sale Price by Type (2015-2020)

3 Global Subcutaneous Immunoglobulins by Company
3.1 Global Subcutaneous Immunoglobulins Sales Market Share by Company
3.1.1 Global Subcutaneous Immunoglobulins Sales by Company (2018-2020)
3.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Company (2018-2020)
3.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Company
3.2.1 Global Subcutaneous Immunoglobulins Revenue by Company (2018-2020)
3.2.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Company (2018-2020)
3.3 Global Subcutaneous Immunoglobulins Sale Price by Company
3.4 Global Subcutaneous Immunoglobulins Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Subcutaneous Immunoglobulins Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Subcutaneous Immunoglobulins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Subcutaneous Immunoglobulins by Regions
4.1 Subcutaneous Immunoglobulins by Regions
4.2 Americas Subcutaneous Immunoglobulins Consumption Growth
4.3 APAC Subcutaneous Immunoglobulins Consumption Growth
4.4 Europe Subcutaneous Immunoglobulins Consumption Growth
4.5 Middle East & Africa Subcutaneous Immunoglobulins Consumption Growth

5 Americas
5.1 Americas Subcutaneous Immunoglobulins Consumption by Countries
5.1.1 Americas Subcutaneous Immunoglobulins Consumption by Countries (2015-2020)
5.1.2 Americas Subcutaneous Immunoglobulins Value by Countries (2015-2020)
5.2 Americas Subcutaneous Immunoglobulins Consumption by Type
5.3 Americas Subcutaneous Immunoglobulins Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Subcutaneous Immunoglobulins Consumption by Regions
6.1.1 APAC Subcutaneous Immunoglobulins Consumption by Regions (2015-2020)
6.1.2 APAC Subcutaneous Immunoglobulins Value by Regions (2015-2020)
6.2 APAC Subcutaneous Immunoglobulins Consumption by Type
6.3 APAC Subcutaneous Immunoglobulins Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Subcutaneous Immunoglobulins by Countries
7.1.1 Europe Subcutaneous Immunoglobulins Consumption by Countries (2015-2020)
7.1.2 Europe Subcutaneous Immunoglobulins Value by Countries (2015-2020)
7.2 Europe Subcutaneous Immunoglobulins Consumption by Type
7.3 Europe Subcutaneous Immunoglobulins Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Subcutaneous Immunoglobulins by Countries
8.1.1 Middle East & Africa Subcutaneous Immunoglobulins Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Subcutaneous Immunoglobulins Value by Countries (2015-2020)
8.2 Middle East & Africa Subcutaneous Immunoglobulins Consumption by Type
8.3 Middle East & Africa Subcutaneous Immunoglobulins Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Subcutaneous Immunoglobulins Distributors
10.3 Subcutaneous Immunoglobulins Customer

11 Global Subcutaneous Immunoglobulins Market Forecast
11.1 Global Subcutaneous Immunoglobulins Consumption Forecast (2021-2025)
11.2 Global Subcutaneous Immunoglobulins Forecast by Regions
11.2.1 Global Subcutaneous Immunoglobulins Forecast by Regions (2021-2025)
11.2.2 Global Subcutaneous Immunoglobulins Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Subcutaneous Immunoglobulins Forecast by Type
11.8 Global Subcutaneous Immunoglobulins Forecast by Application

12 Key Players Analysis
12.1 Shire (Baxalta)
12.1.1 Company Information
12.1.2 Subcutaneous Immunoglobulins Product Offered
12.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Shire (Baxalta) Latest Developments
12.2 Grifols
12.2.1 Company Information
12.2.2 Subcutaneous Immunoglobulins Product Offered
12.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Grifols Latest Developments
12.3 CSL
12.3.1 Company Information
12.3.2 Subcutaneous Immunoglobulins Product Offered
12.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 CSL Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Subcutaneous Immunoglobulins Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 10% Purity
Table 5. Major Players of 20% Purity
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Subcutaneous Immunoglobulins Consumption Market Share by Type (2015-2020)
Table 8. Global Subcutaneous Immunoglobulins Revenue by Type (2015-2020) ($ million)
Table 9. Global Subcutaneous Immunoglobulins Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Subcutaneous Immunoglobulins Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Subcutaneous Immunoglobulins Consumption Market Share by Application (2015-2020)
Table 13. Global Subcutaneous Immunoglobulins Value by Application (2015-2020)
Table 14. Global Subcutaneous Immunoglobulins Value Market Share by Application (2015-2020)
Table 15. Global Subcutaneous Immunoglobulins Sale Price by Application (2015-2020)
Table 16. Global Subcutaneous Immunoglobulins Sales by Company (2017-2019) (K Bottle)
Table 17. Global Subcutaneous Immunoglobulins Sales Market Share by Company (2017-2019)
Table 18. Global Subcutaneous Immunoglobulins Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Subcutaneous Immunoglobulins Revenue Market Share by Company (2017-2019)
Table 20. Global Subcutaneous Immunoglobulins Sale Price by Company (2017-2019)
Table 21. Global Subcutaneous Immunoglobulins Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Subcutaneous Immunoglobulins Products Offered
Table 23. Subcutaneous Immunoglobulins Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Subcutaneous Immunoglobulins Consumption by Regions 2015-2020 (K Bottle)
Table 25. Global Subcutaneous Immunoglobulins Consumption Market Share by Regions 2015-2020
Table 26. Global Subcutaneous Immunoglobulins Value by Regions 2015-2020 ($ Millions)
Table 27. Global Subcutaneous Immunoglobulins Value Market Share by Regions 2015-2020
Table 28. Americas Subcutaneous Immunoglobulins Consumption by Countries (2015-2020) (K Bottle)
Table 29. Americas Subcutaneous Immunoglobulins Consumption Market Share by Countries (2015-2020)
Table 30. Americas Subcutaneous Immunoglobulins Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Subcutaneous Immunoglobulins Value Market Share by Countries (2015-2020)
Table 32. Americas Subcutaneous Immunoglobulins Consumption by Type (2015-2020) (K Bottle)
Table 33. Americas Subcutaneous Immunoglobulins Consumption Market Share by Type (2015-2020)
Table 34. Americas Subcutaneous Immunoglobulins Consumption by Application (2015-2020) (K Bottle)
Table 35. Americas Subcutaneous Immunoglobulins Consumption Market Share by Application (2015-2020)
Table 36. APAC Subcutaneous Immunoglobulins Consumption by Countries (2015-2020) (K Bottle)
Table 37. APAC Subcutaneous Immunoglobulins Consumption Market Share by Countries (2015-2020)
Table 38. APAC Subcutaneous Immunoglobulins Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Subcutaneous Immunoglobulins Value Market Share by Regions (2015-2020)
Table 40. APAC Subcutaneous Immunoglobulins Consumption by Type (2015-2020) (K Bottle)
Table 41. APAC Subcutaneous Immunoglobulins Consumption Market Share by Type (2015-2020)
Table 42. APAC Subcutaneous Immunoglobulins Consumption by Application (2015-2020) (K Bottle)
Table 43. APAC Subcutaneous Immunoglobulins Consumption Market Share by Application (2015-2020)
Table 44. Europe Subcutaneous Immunoglobulins Consumption by Countries (2015-2020) (K Bottle)
Table 45. Europe Subcutaneous Immunoglobulins Consumption Market Share by Countries (2015-2020)
Table 46. Europe Subcutaneous Immunoglobulins Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Subcutaneous Immunoglobulins Value Market Share by Countries (2015-2020)
Table 48. Europe Subcutaneous Immunoglobulins Consumption by Type (2015-2020) (K Bottle)
Table 49. Europe Subcutaneous Immunoglobulins Consumption Market Share by Type (2015-2020)
Table 50. Europe Subcutaneous Immunoglobulins Consumption by Application (2015-2020) (K Bottle)
Table 51. Europe Subcutaneous Immunoglobulins Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Subcutaneous Immunoglobulins Consumption by Countries (2015-2020) (K Bottle)
Table 53. Middle East & Africa Subcutaneous Immunoglobulins Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Subcutaneous Immunoglobulins Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Subcutaneous Immunoglobulins Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Subcutaneous Immunoglobulins Consumption by Type (2015-2020) (K Bottle)
Table 57. Middle East & Africa Subcutaneous Immunoglobulins Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Subcutaneous Immunoglobulins Consumption by Application (2015-2020) (K Bottle)
Table 59. Middle East & Africa Subcutaneous Immunoglobulins Consumption Market Share by Application (2015-2020)
Table 60. Subcutaneous Immunoglobulins Distributors List
Table 61. Subcutaneous Immunoglobulins Customer List
Table 62. Global Subcutaneous Immunoglobulins Consumption Forecast by Countries (2021-2025) (K Bottle)
Table 63. Global Subcutaneous Immunoglobulins Consumption Market Forecast by Regions
Table 64. Global Subcutaneous Immunoglobulins Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Subcutaneous Immunoglobulins Value Market Share Forecast by Regions
Table 66. Global Subcutaneous Immunoglobulins Consumption Forecast by Type (2021-2025) (K Bottle)
Table 67. Global Subcutaneous Immunoglobulins Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Subcutaneous Immunoglobulins Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Subcutaneous Immunoglobulins Value Market Share Forecast by Type (2021-2025)
Table 70. Global Subcutaneous Immunoglobulins Consumption Forecast by Application (2021-2025) (K Bottle)
Table 71. Global Subcutaneous Immunoglobulins Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Subcutaneous Immunoglobulins Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Subcutaneous Immunoglobulins Value Market Share Forecast by Application (2021-2025)
Table 74. Shire (Baxalta) Product Offered
Table 75. Shire (Baxalta) Subcutaneous Immunoglobulins Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 76. Shire (Baxalta) Main Business
Table 77. Shire (Baxalta) Latest Developments
Table 78. Shire (Baxalta) Basic Information, Company Total Revenue (in $ million), Subcutaneous Immunoglobulins Manufacturing Base, Sales Area and Its Competitors
Table 79. Grifols Product Offered
Table 80. Grifols Subcutaneous Immunoglobulins Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 81. Grifols Main Business
Table 82. Grifols Latest Developments
Table 83. Grifols Basic Information, Company Total Revenue (in $ million), Subcutaneous Immunoglobulins Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Product Offered
Table 85. CSL Subcutaneous Immunoglobulins Sales (K Bottle), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2018-2020E)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. CSL Basic Information, Company Total Revenue (in $ million), Subcutaneous Immunoglobulins Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Subcutaneous Immunoglobulins
Figure 2. Subcutaneous Immunoglobulins Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Subcutaneous Immunoglobulins Consumption Growth Rate 2015-2025 (K Bottle)
Figure 5. Global Subcutaneous Immunoglobulins Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 10% Purity
Figure 7. Product Picture of 20% Purity
Figure 8. Global Subcutaneous Immunoglobulins Consumption Market Share by Type (2015-2020)
Figure 9. Global Subcutaneous Immunoglobulins Value Market Share by Type (2015-2020)
Figure 10. Subcutaneous Immunoglobulins Consumed in Primary Immunodeficiency
Figure 11. Global Subcutaneous Immunoglobulins Market: Primary Immunodeficiency (2015-2020) (K Bottle)
Figure 12. Global Subcutaneous Immunoglobulins Market: Primary Immunodeficiency (2015-2020) ($ Millions)
Figure 13. Subcutaneous Immunoglobulins Consumed in Secondary Immunodeficiency
Figure 14. Global Subcutaneous Immunoglobulins Market: Secondary Immunodeficiency (2015-2020) (K Bottle)
Figure 15. Global Subcutaneous Immunoglobulins Market: Secondary Immunodeficiency (2015-2020) ($ Millions)
Figure 16. Subcutaneous Immunoglobulins Consumed in Others
Figure 17. Global Subcutaneous Immunoglobulins Market: Others (2015-2020) (K Bottle)
Figure 18. Global Subcutaneous Immunoglobulins Market: Others (2015-2020) ($ Millions)
Figure 19. Global Subcutaneous Immunoglobulins Consumption Market Share by Application (2015-2020)
Figure 20. Global Subcutaneous Immunoglobulins Value Market Share by Application (2015-2020)
Figure 21. Global Subcutaneous Immunoglobulins Sales Market Share by Company in 2017
Figure 22. Global Subcutaneous Immunoglobulins Sales Market Share by Company in 2019
Figure 23. Global Subcutaneous Immunoglobulins Revenue Market Share by Company in 2017
Figure 24. Global Subcutaneous Immunoglobulins Revenue Market Share by Company in 2019
Figure 25. Global Subcutaneous Immunoglobulins Sale Price by Company in 2019
Figure 26. Global Subcutaneous Immunoglobulins Consumption Market Share by Regions 2015-2020
Figure 27. Global Subcutaneous Immunoglobulins Value Market Share by Regions 2015-2020
Figure 28. Americas Subcutaneous Immunoglobulins Consumption 2015-2020 (K Bottle)
Figure 29. Americas Subcutaneous Immunoglobulins Value 2015-2020 ($ Millions)
Figure 30. APAC Subcutaneous Immunoglobulins Consumption 2015-2020 (K Bottle)
Figure 31. APAC Subcutaneous Immunoglobulins Value 2015-2020 ($ Millions)
Figure 32. Europe Subcutaneous Immunoglobulins Consumption 2015-2020 (K Bottle)
Figure 33. Europe Subcutaneous Immunoglobulins Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Subcutaneous Immunoglobulins Consumption 2015-2020 (K Bottle)
Figure 35. Middle East & Africa Subcutaneous Immunoglobulins Value 2015-2020 ($ Millions)
Figure 36. Americas Subcutaneous Immunoglobulins Consumption Market Share by Countries in 2019
Figure 37. Americas Subcutaneous Immunoglobulins Value Market Share by Countries in 2019
Figure 38. Americas Subcutaneous Immunoglobulins Consumption Market Share by Type in 2019
Figure 39. Americas Subcutaneous Immunoglobulins Consumption Market Share by Application in 2019
Figure 40. United States Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 41. United States Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 43. Canada Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 45. Mexico Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Subcutaneous Immunoglobulins Consumption Market Share by Countries in 2019
Figure 47. APAC Subcutaneous Immunoglobulins Value Market Share by Regions in 2019
Figure 48. APAC Subcutaneous Immunoglobulins Consumption Market Share by Type in 2019
Figure 49. APAC Subcutaneous Immunoglobulins Consumption Market Share by Application in 2019
Figure 50. China Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 51. China Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 53. Japan Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 55. Korea Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 57. Southeast Asia Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 58. India Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 59. India Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 61. Australia Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Subcutaneous Immunoglobulins Consumption Market Share by Countries in 2019
Figure 63. Europe Subcutaneous Immunoglobulins Value Market Share by Countries in 2019
Figure 64. Europe Subcutaneous Immunoglobulins Consumption Market Share by Type in 2019
Figure 65. Europe Subcutaneous Immunoglobulins Consumption Market Share by Application in 2019
Figure 66. Germany Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 67. Germany Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 68. France Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 69. France Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 70. UK Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 71. UK Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 73. Italy Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 75. Russia Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 76. Spain Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 77. Spain Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Subcutaneous Immunoglobulins Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Subcutaneous Immunoglobulins Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Subcutaneous Immunoglobulins Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Subcutaneous Immunoglobulins Consumption Market Share by Application in 2019
Figure 82. Egypt Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 83. Egypt Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 85. South Africa Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 87. Israel Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 89. Turkey Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Subcutaneous Immunoglobulins Consumption Growth 2015-2020 (K Bottle)
Figure 91. GCC Countries Subcutaneous Immunoglobulins Value Growth 2015-2020 ($ Millions)
Figure 92. Global Subcutaneous Immunoglobulins Consumption Growth Rate Forecast (2021-2025) (K Bottle)
Figure 93. Global Subcutaneous Immunoglobulins Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 95. Americas Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 96. APAC Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 97. APAC Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 98. Europe Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 99. Europe Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 101. Middle East & Africa Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 102. United States Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 103. United States Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 104. Canada Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 105. Canada Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 106. Mexico Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 107. Mexico Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 108. Brazil Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 109. Brazil Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 110. China Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 111. China Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 112. Japan Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 113. Japan Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 114. Korea Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 115. Korea Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 117. Southeast Asia Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 118. India Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 119. India Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 120. Australia Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 121. Australia Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 122. Germany Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 123. Germany Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 124. France Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 125. France Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 126. UK Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 127. UK Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 128. Italy Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 129. Italy Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 130. Russia Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 131. Russia Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 132. Spain Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 133. Spain Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 134. Egypt Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 135. Egypt Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 136. South Africa Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 137. South Africa Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 138. Israel Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 139. Israel Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 140. Turkey Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 141. Turkey Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Subcutaneous Immunoglobulins Consumption 2021-2025 (K Bottle)
Figure 143. GCC Countries Subcutaneous Immunoglobulins Value 2021-2025 ($ Millions)
Figure 144. Shire (Baxalta) Subcutaneous Immunoglobulins Market Share (2018-2020)
Figure 145. Grifols Subcutaneous Immunoglobulins Market Share (2018-2020)
Figure 146. CSL Subcutaneous Immunoglobulins Market Share (2018-2020)


★調査レポート[世界の皮下免疫グロブリン市場予測 2020年-2025年] (コード:LPI20AP4677)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の皮下免疫グロブリン市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆